Effect of Pomegranate Seed Powder on Markers of Metabolic Syndrome - Trial NCT05944029
Access comprehensive clinical trial information for NCT05944029 through Pure Global AI's free database. This phase not specified trial is sponsored by Asif Ali and is currently Recruiting. The study focuses on Metabolic Syndrome. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Asif Ali
University of Veterinary and Animal Sciences, Lahore - Pakistan
Timeline & Enrollment
N/A
Feb 20, 2023
Aug 24, 2023
Primary Outcome
Lipid Profile,Fasting Glucose,Blood Pressure,Weight
Summary
Metabolic syndrome is a public health concern worldwide and in Pakistan as well. Abdominal
 obesity, hyperglycemia, hypertriglyceridemia, hypertension, and low HDL cholesterol are its
 hallmarks while pomegranate seed's unique chemical composition has sparked research into the
 health benefits in same arena as weight control, blood lipid profile changes, and other
 metabolic disturbances. It's high time to study therapeutic efficiency of Pomegranate seed
 powder against metabolic syndrome.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05944029
Non-Device Trial